TNF-α converting enzyme (TACE), also known as ADAM17, cleaves the extracellular domain of TGFβRI, which is released extracellularly and results in downregulation of TGF-β receptor signaling as it was demonstrated in HaCaT keratinocytes and in breast cancer cells [208]. This evidence concerns the gene ADAM17 and breast carcinoma.